Literature DB >> 12785009

Endotoxin stimulates in vivo expression of inflammatory cytokines tumor necrosis factor alpha, interleukin-1beta, -6, and high-mobility-group protein-1 in skeletal muscle.

Charles H Lang1, Christine Silvis, Nobuko Deshpande, Gerald Nystrom, Robert A Frost.   

Abstract

The presence of increased levels of proinflammatory cytokines in the blood is associated with decreased muscle protein synthesis and the erosion of lean body mass in many catabolic conditions. However, little is known regarding the role of endogenous cytokine synthesis in muscle per se. The purpose of the present study was to characterize the cytokine expression profile of skeletal muscle in response to an in vivo injection of endotoxin (lipopolysaccharide, LPS). Intraperitoneal injection of a nonlethal dose of LPS (1,000 microg/kg Escherichia coli) into male rats increased the mRNA content of tumor necrosis factor-alpha (TNF-alpha) and interleukin (IL)-1beta in gastrocnemius muscle as early as 1 h; IL-6 mRNA was not increased until 2 h post-LPS. Expression of TNF-alpha and IL-1beta peaked at 2 h (10- and 80-fold, respectively), whereas the increased IL-6 mRNA content (150-fold) peaked later at 4 h. The abundance of all measured cytokine mRNAs in skeletal muscle declined thereafter. The LPS-induced increase in muscle mRNA content for TNF-alpha, IL-6, and IL-1beta was dose-dependent with elevations being seen with as little as 10 microg/kg of LPS (2.5-, 8-, and 9-fold, respectively). In general, pretreatment of rats with dexamethasone attenuated but did not completely prevent the LPS-induced increase in muscle cytokine mRNA. LPS increased muscle TNF-alpha protein content approximately 2-fold and this increase was prevented by pretreatment with dexamethasone. LPS-induced increases in muscle IL-1beta and IL-6 protein were not detected. LPS also produced a 2-fold increase in the mRNA content of the high-mobility-group protein-1, a late-phase cytokine, in muscle at 12-24 h. Finally, although skeletal muscle was found to contain both the toll-like receptor (TLR)-2 and TLR4, LPS did not alter the mRNA content of TLR4 and produced a small (50%) but significant increase in TLR2 mRNA. These changes in TLRs were less dramatic than those observed for liver, spleen or cardiac muscle. Collectively these data indicate that skeletal muscle possesses many of the components of the innate immune system, including increases in both early- and late-phase cytokines and the presence of toll-like receptors.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12785009     DOI: 10.1097/01.shk.0000055237.25446.80

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  66 in total

1.  Lipopolysaccharide induces and activates the Nalp3 inflammasome in the liver.

Authors:  Michal Ganz; Timea Csak; Bharath Nath; Gyongyi Szabo
Journal:  World J Gastroenterol       Date:  2011-11-21       Impact factor: 5.742

2.  Disruption of REDD1 gene ameliorates sepsis-induced decrease in mTORC1 signaling but has divergent effects on proteolytic signaling in skeletal muscle.

Authors:  Jennifer L Steiner; Kristen T Crowell; Scot R Kimball; Charles H Lang
Journal:  Am J Physiol Endocrinol Metab       Date:  2015-10-20       Impact factor: 4.310

3.  Toll-like receptor 4 modulates skeletal muscle substrate metabolism.

Authors:  Madlyn I Frisard; Ryan P McMillan; Julie Marchand; Kristin A Wahlberg; Yaru Wu; Kevin A Voelker; Leonie Heilbronn; Kimberly Haynie; Brendan Muoio; Liwu Li; Matthew W Hulver
Journal:  Am J Physiol Endocrinol Metab       Date:  2010-02-23       Impact factor: 4.310

Review 4.  Metabolic syndrome and insulin resistance: underlying causes and modification by exercise training.

Authors:  Christian K Roberts; Andrea L Hevener; R James Barnard
Journal:  Compr Physiol       Date:  2013-01       Impact factor: 9.090

5.  PYK2 interacts with MyD88 and regulates MyD88-mediated NF-kappaB activation in macrophages.

Authors:  Cai-Xia Xi; Fei Xiong; Zheng Zhou; Lin Mei; Wen-Cheng Xiong
Journal:  J Leukoc Biol       Date:  2009-12-02       Impact factor: 4.962

6.  Inhibition of lipopolysaccharide-induced interferon regulatory factor 3 activation and protection from septic shock by hydroxystilbenes.

Authors:  Oanh Dang; Lorena Navarro; Michael David
Journal:  Shock       Date:  2004-05       Impact factor: 3.454

7.  Exaggerated expression of skeletal muscle-derived interleukin-6, but not TNFalpha, in mice lacking interleukin-10.

Authors:  Kimberly A Huey; Robert H McCusker; Keith W Kelley
Journal:  J Neuroimmunol       Date:  2008-06-18       Impact factor: 3.478

Review 8.  High mobility group box 1 protein as a potential drug target for infection- and injury-elicited inflammation.

Authors:  Shu Zhu; Wei Li; Mary F Ward; Andrew E Sama; Haichao Wang
Journal:  Inflamm Allergy Drug Targets       Date:  2010-03

Review 9.  Cachexia in chronic heart failure: endocrine determinants and treatment perspectives.

Authors:  Norman Mangner; Yae Matsuo; Gerhard Schuler; Volker Adams
Journal:  Endocrine       Date:  2012-08-19       Impact factor: 3.633

10.  Inflammation and adipose tissue: effects of progressive load training in rats.

Authors:  Fábio S Lira; José C Rosa; Gustavo D Pimentel; Victor A F Tarini; Ricardo M Arida; Flávio Faloppa; Eduardo S Alves; Cláudia O do Nascimento; Lila M Oyama; Marília Seelaender; Marco T de Mello; Ronaldo V T Santos
Journal:  Lipids Health Dis       Date:  2010-10-04       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.